Sustainability
As a pharmaceutical and healthcare company, STADA is responsible for ensuring the group-wide safety of its products and thus also the safety of patients. That’s what SDG 17 is all about.
Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (1)
Austria (1)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
The Phillippines (1)
United Kingdom (3)
Vietnam (2)
Explore STADA
Your opportunity for success with STADA
We are looking for qualified employees who drive our company forward with their specialist knowledge and commitment. We offer appealing conditions with diverse and exciting tasks as well as good career prospects and a motivating working environment.
Proud to be back in the Kingdom of Saudi Arabia,...
By Stéphane Jacqmin, EVP Emerging Markets at STADA Group
I don’t like looking back and therefore let’s make 2025 the “Blockbuster year for Stada CHC”.
By Karsten Kloebbe,
Don't stop the beast: STADA Specialty Germany looks back on a successful year 2024 and is highly motivated for the new year 2025!
By Martin Spatz,
Today, STADA Group announced that Andreas Fibig has been retained as the independent Chairman of our future Board of Directors, in the event of an IPO.
Peter Goldschmidt, CEO, STADA
Here’s to another year of collaboration, passion, and success! 🎉
Stefanie Glaser, Team Lead Category Management & Customer Engagement at STADA Group
STADA Voices
Latest news
09/01/2025
STADA sets course for the future- experienced healthcare manager Andreas Fibig to become Chairman of the Board
10/10/2024
EMA accepts Marketing Authorization Applications for AVT03, a Proposed Denosumab Biosimilar
26/07/2024
European Commission approval to expand label & patient group for IgA Nephropathy orphan medicine
24/06/2024
STADA Health Report 2024: Satisfaction with healthcare systems continues to decline
At STADA Group, our Vision is to outgrow the industry and to deliver strong market share growth. And that’s exactly what the STADA Saudi Arabia team did in 2024, for the 4th time in a row. That’s clearly not a coincidence; it speaks to the many colleagues who have been building a very strong and leading marketing and sales platform that allows us to expand our portfolio, bring innovations to patients and consumers, and ultimately deliver on our Purpose of Caring for People’s Health as a Trusted Partner.
Congratulations to all the colleagues from STADA Saudi Arabia for this awesome performance. At STADA Group, we are committed to this important market where we can see exceptional growth potential.
#CaringforPeople’Health